Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Multiple myeloma with IgH::MYC and multiple extramedullary lesions].
Sasaki Y, Ichikawa S, Sakurai K, Nakamura H, Inokura K, Onodera K, Fukuhara N, Onishi Y, Yokoyama H, Harigae H. Sasaki Y, et al. Among authors: harigae h. Rinsho Ketsueki. 2024;65(3):147-152. doi: 10.11406/rinketsu.65.147. Rinsho Ketsueki. 2024. PMID: 38569857 Japanese.
Diffuse large B-cell lymphoma of the skull vault.
Ichikawa S, Yokoyama H, Fukuhara N, Ichinohasama R, Harigae H. Ichikawa S, et al. Among authors: harigae h. Int J Hematol. 2024 Mar;119(3):215-216. doi: 10.1007/s12185-024-03717-z. Epub 2024 Jan 30. Int J Hematol. 2024. PMID: 38289575 No abstract available.
[Academia-Industry Alliance: Recent Trend].
Nakagawa A, Perl L, Lee J, Harada-Shoji N, Ota C, Shiga T, Sunami S, Niizuma K, Endo H, Harigae H, Tominaga T. Nakagawa A, et al. Among authors: harigae h. No Shinkei Geka. 2024 Jan;52(1):213-225. doi: 10.11477/mf.1436204899. No Shinkei Geka. 2024. PMID: 38246689 Japanese.
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
Dreyling M, Fowler NH, Dickinson M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, María Ferreri AJ, Teshima T, Patten PEM, McGuirk JP, Petzer AL, Offner F, Viardot A, Zinzani PL, Malladi R, Paule I, Zia A, Awasthi R, Han X, Germano D, O'Donovan D, Ramos R, Maier HJ, Masood A, Thieblemont C, Schuster SJ. Dreyling M, et al. Among authors: harigae h. Blood. 2024 Apr 25;143(17):1713-1725. doi: 10.1182/blood.2023021567. Blood. 2024. PMID: 38194692 Free article. Clinical Trial.
A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19.
Hirai T, Asano K, Ito I, Miyazaki Y, Sugiura H, Agirbasli M, Kobayashi S, Kobayashi M, Shimada D, Natsume I, Kawasaki T, Ohba T, Tajiri S, Sakamaki F, Mineshita M, Takihara T, Sekiya K, Tomii K, Tomioka H, Kita H, Nishizaka Y, Fukui M, Miyata T, Harigae H. Hirai T, et al. Among authors: harigae h. Sci Rep. 2024 Jan 2;14(1):165. doi: 10.1038/s41598-023-50445-1. Sci Rep. 2024. PMID: 38168544 Free PMC article. Clinical Trial.
Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes with Donor-Specific Anti-HLA Antibodies against HLA-DP.
Uchibori Y, Onodera K, Onishi Y, Komatsu H, Takenaka K, Narumi Y, Watanabe T, Nakamura H, Sakurai K, Hashimoto K, Inokura K, Ichikawa S, Fukuhara N, Yokoyama H, Harigae H. Uchibori Y, et al. Among authors: harigae h. Tohoku J Exp Med. 2023 Oct 17;261(2):123-127. doi: 10.1620/tjem.2023.J063. Epub 2023 Aug 10. Tohoku J Exp Med. 2023. PMID: 37558420 Free article.
[Overview].
Harigae H. Harigae H. Rinsho Ketsueki. 2023;64(6):465. doi: 10.11406/rinketsu.64.465. Rinsho Ketsueki. 2023. PMID: 37407468 Japanese. No abstract available.
353 results